These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 22294488)
1. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. Gravgaard KH; Lyng MB; Laenkholm AV; Søkilde R; Nielsen BS; Litman T; Ditzel HJ Breast Cancer Res Treat; 2012 Jul; 134(1):207-17. PubMed ID: 22294488 [TBL] [Abstract][Full Text] [Related]
2. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
3. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Santarpia L; Calin GA; Adam L; Ye L; Fusco A; Giunti S; Thaller C; Paladini L; Zhang X; Jimenez C; Trimarchi F; El-Naggar AK; Gagel RF Endocr Relat Cancer; 2013 Dec; 20(6):809-23. PubMed ID: 24127332 [TBL] [Abstract][Full Text] [Related]
4. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases. Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678 [TBL] [Abstract][Full Text] [Related]
5. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127 [TBL] [Abstract][Full Text] [Related]
6. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119 [TBL] [Abstract][Full Text] [Related]
8. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. Du J; Yang S; An D; Hu F; Yuan W; Zhai C; Zhu T Cell Res; 2009 Apr; 19(4):487-96. PubMed ID: 19308091 [TBL] [Abstract][Full Text] [Related]
9. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773 [TBL] [Abstract][Full Text] [Related]
10. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach. Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977 [TBL] [Abstract][Full Text] [Related]
11. Global microRNA profiling of metastatic conjunctival melanoma. Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942 [TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes. Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861 [TBL] [Abstract][Full Text] [Related]
13. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026 [TBL] [Abstract][Full Text] [Related]
15. The role of microRNA-200 in progression of human colorectal and breast cancer. Bojmar L; Karlsson E; Ellegård S; Olsson H; Björnsson B; Hallböök O; Larsson M; Stål O; Sandström P PLoS One; 2013; 8(12):e84815. PubMed ID: 24376848 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line. Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606 [TBL] [Abstract][Full Text] [Related]
17. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666 [TBL] [Abstract][Full Text] [Related]
18. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. Dykxhoorn DM; Wu Y; Xie H; Yu F; Lal A; Petrocca F; Martinvalet D; Song E; Lim B; Lieberman J PLoS One; 2009 Sep; 4(9):e7181. PubMed ID: 19787069 [TBL] [Abstract][Full Text] [Related]
19. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis. Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740 [TBL] [Abstract][Full Text] [Related]
20. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]